注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   基因重组   >   Anti-Complement C2 Reference Antibody (ARGX-117)   

Anti-Complement C2 Reference Antibody (ARGX-117)

Recombinant Antibody

     
  • 0 - Anti-Complement C2 Reference Antibody (ARGX-117) APR10145
    Anti-Complement C2 Reference Antibody (ARGX-117) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-Complement C2 Reference Antibody (ARGX-117) APR10145
    The purity of Anti-Complement C2 Reference Antibody (ARGX-117) is 100%, determined by SEC-HPLC.
  • 0 - Anti-Complement C2 Reference Antibody (ARGX-117) APR10145
    Immobilized human Complement C2 Protein at 2 ug/mL can bind Anti-Complement C2 Reference Antibody (ARGX-117), EC50=0.004283 ug/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P06681
Reactivity Human
Clonality Monoclonal
Isotype IgG1
Calculated MW 83268 Da
Additional Information
Target/Specificity Complement C2
Endotoxin < 0.001EU/ µg,determined by LAL method.
Conjugation Unconjugated
Expression system CHO
Format Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name C2 {ECO:0000303|PubMed:2949737, ECO:0000312|HGNC:HGNC:1248}
Function Precursor of the catalytic component of the C3 and C5 convertase complexes, which are part of the complement pathway, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12878586, PubMed:17027507, PubMed:18204047, PubMed:39914456, PubMed:39814882). Component C2 is part of the classical, lectin and GZMK complement systems (PubMed:12878586, PubMed:17027507, PubMed:18204047, PubMed:22691502, PubMed:39914456).
Cellular Location Secreted. Cell surface. Note=Recruited to the surface of pathogens by complement C3b and complement C4b opsonins
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价